The top-performing pharma and biotech stocks as group sees resurgence
Source: SeekingAlpha
2026-02-13 14:01:58 ET
More on pharmaceuticals, biotech
- Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More
- BBH: Mature Biotech Exposure, But Limited Growth Ahead
- XPH: Healthcare Dashboard For January
- Most and least shorted mid-to mega-cap healthcare stocks in January
- FDA opens fast-track program to speed U.S. drug plant construction
Read the full article on Seeking Alpha
For further details see:
The top-performing pharma and biotech stocks as group sees resurgence
Septerna Inc.
NASDAQ: SEPN
SEPN Trading
-2.48% G/L:
$26.295 Last:
132,173 Volume:
$25.86 Open:
SEPN Latest News
March 09, 2026 04:05:00 pm
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
March 01, 2026 09:45:00 am
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
February 10, 2026 04:05:00 pm
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SEPN Stock Data
$1,195,470,926
19,969,290
0.21%
25
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
